Multivariate Analysis of CT Imaging, Laboratory, and Demographical Features for Prediction of Acute Kidney Injury in COVID-19 Patients: a Bi-centric Analysis
Overview
Radiology
Authors
Affiliations
Purpose: To develop and externally validate a multivariate prediction model for the prediction of acute kidney injury (AKI) in COVID-19, based on baseline renal perfusion from contrast-enhanced CT together with clinical and laboratory parameters.
Methods: In this retrospective IRB-approved study, we identified COVID-19 patients who had a standard-of-care contrast-enhanced abdominal CT scan within 5 days of their COVID-19 diagnosis at our institution (training set; n = 45, mean age 65 years, M/F 23/22) and at a second institution (validation set; n = 41, mean age 61 years, M/F 22/19). The CT renal perfusion parameter, cortex-to-aorta enhancement index (CAEI), was measured in both sets. A multivariate logistic regression model for predicting AKI was constructed from the training set with stepwise feature selection with CAEI together with demographical and baseline laboratory/clinical data used as input variables. Model performance in the training and validation set was evaluated with ROC analysis.
Results: AKI developed in 16 patients (35.6%) of the training set and in 6 patients (14.6%) of the validation set. Baseline CAEI was significantly lower in the patients that ultimately developed AKI (P = 0.003). Logistic regression identified a model combining baseline CAEI, blood urea nitrogen, and gender as most significant predictor of AKI. This model showed excellent diagnostic performance for prediction of AKI in the training set (AUC = 0.89, P < 0.001) and good performance in the validation set (AUC 0.78, P = 0.030).
Conclusion: Our results show diminished renal perfusion preceding AKI and a promising role of CAEI, combined with laboratory and demographic markers, for prediction of AKI in COVID-19.
Jiang Y, Zhang J, Ainiwaer A, Liu Y, Li J, Zhou L Ren Fail. 2024; 46(2):2394634.
PMID: 39177235 PMC: 11346321. DOI: 10.1080/0886022X.2024.2394634.
Gerhards C, Haselmann V, Schaible S, Ast V, Kittel M, Thiel M Microorganisms. 2023; 11(7).
PMID: 37512912 PMC: 10384842. DOI: 10.3390/microorganisms11071740.
Russo E, Tagliafico A, Derchi L, Bignotti B, Tosto S, Martinoli C J Clin Med. 2023; 12(3).
PMID: 36769577 PMC: 9918001. DOI: 10.3390/jcm12030929.
Lu J, Zhu J, Zhu J, Duong T Int J Infect Dis. 2022; 122:802-810.
PMID: 35872094 PMC: 9303068. DOI: 10.1016/j.ijid.2022.07.034.
Ghosheh G, Alamad B, Yang K, Syed F, Hayat N, Iqbal I Intell Based Med. 2022; 6:100065.
PMID: 35721825 PMC: 9188985. DOI: 10.1016/j.ibmed.2022.100065.